Arnold Alexander E patents

• Use of substituted 5-(4-methyl-6-phenyl-4h-benzo[f]imidazo[1,5-a][1,4] diazepin-3-yl)-1,2,4-oxadiazoles in the treatment of inflammatory conditions

  US-2024279232-A1 · Aug 22, 2024 · US

• Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators

  US-12054491-B2 · Aug 6, 2024 · US

• Gaba(a) receptor modulators and methods to control airway hyperresponsiveness and inflammation in asthma

  US-2023103216-A1 · Mar 30, 2023 · US

• Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators

  US-11447495-B2 · Sep 20, 2022 · US

• Gaba(a) receptor modulators and methods to control airway hyperresponsiveness and inflammation in asthma

  US-2021284649-A1 · Sep 16, 2021 · US

• Vitamin d receptor-coregulator inhibitors

  US-2018362500-A1 · Dec 20, 2018 · US

• Vitamin D receptor-coregulator inhibitors

  US-10093653-B2 · Oct 9, 2018 · US

• GABAA agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma

  US-9879020-B2 · Jan 30, 2018 · US

• Novel gabaa agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma

  US-2015232473-A1 · Aug 20, 2015 · US

No data yet.